Prasco's Generic Mirtazapine Receives Approval in the U.S.
MASON, Ohio, Nov. 18, 2022 /PRNewswire/ -- Prasco Laboratories announced today the launch of the Authorized Generic of ZIOPTAN® (tafluprost ophthalmic solution) 0.0015%. This is Prasco's first Authorized Generic launch in partnership with Théa Pharma, Inc.